Vosevi- Drug Insight, 2029

SKU ID :DEL-13698711 | Published Date: 01-Jul-2019 | No. of pages: 35
"Vosevi - Drug Insight, 2019" report by provides comprehensive information of the drug, Vosevi. It includes drugs overview, Vosevi mechanism of action, clinical trials, regulatory milestones, deals & Vosevi’s partnerships. It further provides Vosevi`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Vosevi sales till 2021. The report also throws light on Vosevi market competition and emerging therapies in the same space as Vosevi. Vosevi SWOT analysis is also featured. * Depending on information availability
Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by ’s team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.
Scope of the report
• A comprehensive Vosevi overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
• Vosevi Patent information in United States (US) and Europe (EU) has been highlighted
• Vosevi API manufacturers in United States, Europe, China and India
• The report contains historical and forecasted Vosevi sales till 2021
• Comprehensive coverage of the emerging therapies (Phase III) in the space where Vosevi operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
• The report also features the Vosevi SWOT analysis
Reasons to Buy
• Establish a comprehensive understanding of the drug, Vosevi
• Access to Vosevi API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around Vosevi patents for the major markets- US and EU
• Understand current and future Vosevi`s growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for Vosevi
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as Vosevi
• Identify opportunities in the same area as with Vosevi SWOT analysis
  • PRICE
  • $1000
    $3000
    Buy Now

Our Clients